The secretary of Health and Human Services nominee wrote in an ethics agreement that he would keep receiving contingency fees.

Robert F. Kennedy, Jr, the nominee for Secretary of HHS, has made promises about the status of his stake in anti-vaccine nonprofits and notable pharma companies as his confirmation hearing approaches.

The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.

Robert F. Kennedy Jr. would retain legal fees earned from litigation against drugmaker Merck if he is confirmed as President ...

Herrmann will continue in her role as chief of staff to EVP and chief communications and public affairs officer Cristal Downing.

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Merck & Company (MRK – Research Report). The ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Tempus AI claims to have a one-stop-shop, with a flywheel platform that becomes better with each new client. See why I rate ...

Robert F. Kennedy, Jr. – the vaccine skeptic President Donald Trump has nominated to serve as Health and Human Services secretary – plans to retain his financial interest in some litigation brought by ...

Robert F. Kennedy Jr. earned millions from his work as an attorney, including referral fees from cases filed against the ...

RFK Jr. plans to keep collecting referral fees in lawsuits against the drug company Merck even if confirmed as HHS secretary, ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story What RFK Jr.’s disclosures tell us about the Trump HHS pick Robert F. Kennedy Jr., President Trump’s ...